Fact CheckerSign in

NCT07140757Recruiting

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Source: ClinicalTrials.gov · Last updated 16 Sept 2026

Brief summary (registry, in English)

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
22 Aug 2025
Start date
18 Aug 2025
Primary completion date
31 Dec 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT07140757

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 18 Aug 2025 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participants meeting any of the following criteria will be excluded:
  • Participants considered unsuitable for RFA by the treating physician

Criteria the registry did not label

  • Eligibility Criteria
  • Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
  • Participant is over 18 years and is either not a surgical candidate or has declined surgery.
  • Capable and willing to provide written informed consent
  • Participant has one of the following diagnoses:
    • Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
    • Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
    • Papillary thyroid carcinoma (PTC) without metastasis
    • Locally recurrent thyroid cancer (\< 2 cm).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MD Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.